Characterization of a Proteasome and TAP-independent Presentation of Intracellular Epitopes by HLA-B27 Molecules
Fiorillo, M. T.
KAUST Grant NumberKUK-11-012-43
Online Publication Date2012-07-17
Print Publication Date2012-08-31
Permanent link to this recordhttp://hdl.handle.net/10754/597756
MetadataShow full item record
AbstractNascent HLA-class I molecules are stabilized by proteasome-derived peptides in the ER and the new complexes proceed to the cell surface through the post-ER vesicles. It has been shown, however, that less stable complexes can exchange peptides in the Trans Golgi Network (TGN). HLA-B27 are the most studied HLA-class I molecules due to their association with Ankylosing Spondylitis (AS). Chimeric proteins driven by TAT of HIV have been exploited by us to deliver viral epitopes, whose cross-presentation by the HLA-B27 molecules was proteasome and TAP-independent and not restricted to Antigen-Presenting Cells (APC). Here, using these chimeric proteins as epitope suppliers, we compared with each other and with the HLA-A2 molecules, the two HLA-B*2705 and B*2709 alleles differing at residue 116 (D116H) and differentially associated with AS. We found that the antigen presentation by the two HLA-B27 molecules was proteasome-, TAP-, and APC-independent whereas the presentation by the HLA-A2 molecules required proteasome, TAP and professional APC. Assuming that such difference could be due to the unpaired, highly reactive Cys-67 distinguishing the HLA-B27 molecules, C67S mutants in HLA-B*2705 and B*2709 and V67C mutant in HLA-A*0201 were also analyzed. The results showed that this mutation did not influence the HLA-A2-restricted antigen presentation while it drastically affected the HLA-B27-restricted presentation with, however, remarkable differences between B*2705 and B*2709. The data, together with the occurrence on the cell surface of unfolded molecules in the case of C67S-B*2705 mutant but not in that of C67S-B*2709 mutant, indicates that Cys-67 has a more critical role in stabilizing the B*2705 rather than the B*2709 complexes.
CitationMagnacca A, Persiconi I, Nurzia E, Caristi S, Meloni F, et al. (2012) Characterization of a Proteasome and TAP-independent Presentation of Intracellular Epitopes by HLA-B27 Molecules. Journal of Biological Chemistry 287: 30358–30367. Available: http://dx.doi.org/10.1074/jbc.M112.384339.
SponsorsThis work was supported by the Italian Ministry of Education, University and Research (MIUR) through PRIN (grant no2008C33HRL-004), by the Istituto Pasteur-Fondazione Cenci Bolognetti, King Abdullah University of Science and Technology (KAUST) (Award No. KUK-11-012-43) Fondazione Roma and by Sapienza through Progetti di Ateneo (Grant noC26A10CT9F).
JournalJournal of Biological Chemistry
PubMed Central IDPMC3436287
CollectionsPublications Acknowledging KAUST Support
- The Cys-67 residue of HLA-B27 influences cell surface stability, peptide specificity, and T-cell antigen presentation.
- Authors: Alvarez I, Martí M, Vázquez J, Camafeita E, Ogueta S, López de Castro JA
- Issue date: 2001 Dec 28
- The amino acid at position 97 is involved in folding and surface expression of HLA-B27.
- Authors: Blanco-Gelaz MA, Suárez-Alvarez B, González S, López-Vázquez A, Martínez-Borra J, López-Larrea C
- Issue date: 2006 Jan
- HLA-B27 and antigen presentation: at the crossroads between immune defense and autoimmunity.
- Authors: Sorrentino R, Böckmann RA, Fiorillo MT
- Issue date: 2014 Jan
- Role of metalloproteases in vaccinia virus epitope processing for transporter associated with antigen processing (TAP)-independent human leukocyte antigen (HLA)-B7 class I antigen presentation.
- Authors: Lorente E, García R, Mir C, Barriga A, Lemonnier FA, Ramos M, López D
- Issue date: 2012 Mar 23
- High T cell epitope sharing between two HLA-B27 subtypes (B*2705 and B*2709) differentially associated to ankylosing spondylitis.
- Authors: García-Peydró M, Martí M, López de Castro JA
- Issue date: 1999 Aug 15